NOTCH1 and non-small cell lung carcinoma: In NSCLC, Notch-1 contributes to chemoresistance via a Notch-1/AP-1/miR-451/MDR-1 axis, and inhibition of Notch-1 led to increased miR-451 and sensitized tumors to taxane-based treatment[155].